文献速递类风湿关节炎

抗PAD4抗体在类风湿关节炎中的诊断价值、与疾病活动的关联及可能危险因素:一项Meta分析

Diagnostic values, association with disease activity and possible risk factors of anti-PAD4 in rheumatoid arthritis: a meta-analysis.
PubMed 文献 · Rheumatology (Oxford) · 2024-01-01

该Meta分析检索五个数据库截至2022年12月1日的研究,最终纳入24篇期刊论文和1封信件,评估抗肽酰基精氨酸脱亚胺酶4(抗PAD4)抗体在类风湿关节炎(RA)中的诊断价值、与疾病活动的关联及可能危险因素。抗PAD4抗体在RA与健康个体间诊断价值良好,与ACPA或ACPA/RF联合可轻度提高RA诊断敏感性;抗PAD4抗体与HLA-SE正相关、与曾经或当前吸烟负相关,阳性患者DAS28、ESR、肿胀关节计数及间质性肺病和肺纤维化可能性更高。

要点

  • 抗PAD4抗体在RA与健康个体间诊断价值良好,与ACPA或ACPA/RF联合可轻度提高诊断敏感性。
  • 抗PAD4抗体阳性RA患者DAS28、ESR、肿胀关节计数及间质性肺病和肺纤维化可能性高于阴性患者。
  • 抗PAD4抗体与HLA-SE正相关、与曾经或当前吸烟负相关,作者建议进一步机制研究。

核心结论

  • 作者认为抗PAD4抗体是RA潜在有用的诊断生物标志物和临床指标。
  • 作者指出需进一步机制研究以理解HLA-SE和吸烟对抗PAD4抗体产生的影响。

研究设计与样本

  • 检索五个数据库截至2022年12月1日的研究,最终纳入24篇期刊论文和1封信件。
  • 采用双变量混合效应模型合并诊断准确性指标并绘制SROC曲线,用QUADAS-2评估诊断研究质量。
  • 非诊断性Meta分析采用随机效应模型,并用敏感性分析、Meta回归、亚组分析和Deeks漏斗图不对称检验处理异质性。

主要发现

  • 抗PAD4抗体在RA与健康个体间诊断价值良好,但在RA与其他风湿性疾病间可能较低。
  • 抗PAD4抗体联合ACPA或ACPA/RF可轻度提高RA诊断敏感性。
  • 抗PAD4抗体与HLA-SE正相关、与曾经或当前吸烟负相关。
  • 抗PAD4抗体阳性RA患者较阴性者DAS28、ESR、肿胀关节计数及间质性肺病和肺纤维化可能性更高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出需进一步机制研究以理解HLA-SE和吸烟对抗PAD4抗体产生的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Anti-peptidyl arginine deaminase 4 (anti-PAD4) antibody has been a subject of investigation in RA in the last two decades. This meta-analysis investigated the diagnostic values, association with disease activity and possible risk factors of anti-PAD4 antibody in rheumatoid arthritis. METHOD: We searched studies from five databases up to 1 December 2022. Bivariate mixed-effect models were used to pool the diagnostic accuracy indexes, and the summary receiver operating characteristics (SROC) curve was plotted. The quality of diagnostic studies was assessed using QUADAS-2. Non-diagnostic meta-analyses were conducted using the random-effects model. Sensitivity analysis, meta-regression, subgroup analyses and Deeks' funnel plot asymmetry test were used to address heterogeneity. RESULT: Finally, 24 journal articles and one letter were included. Anti-PAD4 antibody had a good diagnostic value between RA and healthy individuals, but it might be lower between RA and other rheumatic diseases. Moreover, anti-PAD4 could slightly enhance RA diagnostic sensitivity with a combination of ACPA or ACPA/RF. Anti-PAD4 antibody was positively correlated with HLA-SE and negatively correlated with ever or current smoking in patients with RA. RA patients with anti-PAD4 antibody had higher DAS28, ESR, swollen joint count (SJC) and the possibility of having interstitial lung disease (ILD) and pulmonary fibrosis compared with those without. CONCLUSION: Our study suggests that anti-PAD4 antibody is a potentially useful diagnostic biomarker and clinical indicator for RA. Further mechanistic studies are required to understand the impact of HLA-SE and smoking on the production of anti-PAD4 antibody.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Zhang G, Xu J, Du D, et al. Diagnostic values, association with disease activity and possible risk factors of anti-PAD4 in rheumatoid arthritis: a meta-analysis. Rheumatology (Oxford). 2024. PMID: 37824204. doi:10.1093/rheumatology/kead545

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。